{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:34:57Z","timestamp":1791250497524,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.amjmed.2003.12.024","type":"journal-article","created":{"date-parts":[[2004,4,15]],"date-time":"2004-04-15T05:36:44Z","timestamp":1082007404000},"page":"590-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results"],"prefix":"10.1016","volume":"116","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Maloisel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Andr\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Zamfir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyro","family":"Koumarianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2003.12.024_BIB1","doi-asserted-by":"crossref","first-page":"40s","DOI":"10.1016\/S0248-8663(99)80146-5","article-title":"Traitement du purpura thrombop\u00e9nique idiopathique de l'adulte","volume":"20","author":"Andr\u00e8s","year":"1999","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-126-4-199702150-00007","article-title":"Therapy for adults with refractory chronic immune thrombocytopenic purpura","volume":"126","author":"McMillan","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-96-5-625","article-title":"Danazol","volume":"96","author":"Madanes","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJM198306093082306","article-title":"Danazol for the treatment of idiopathic thrombocytopenic purpura","volume":"308","author":"Ahn","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-111-9-723","article-title":"Long-term danazol therapy in autoimmune thrombocytopenia","volume":"111","author":"Ahn","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0897.1990.tb01037.x","article-title":"Danazol suppresses the production of interleukin-1 and tumor necrosis factor by human monocytes","volume":"24","author":"Mori","year":"1990","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1054\/blre.2001.0183","article-title":"Classical management of refractory adult immune (idiopathic) thrombocytopenic purpura","volume":"16","author":"McMillan","year":"2002","journal-title":"Blood Rev"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-107-2-177","article-title":"Low-dose danazol therapy in idiopathic thrombocytopenic purpura","volume":"107","author":"Ahn","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB10","first-page":"55","article-title":"Danazol therapy for idiopathic thrombocytopenic purpura","volume":"73","author":"Nalli","year":"1988","journal-title":"Haematologica"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000205948","article-title":"Danazol therapy in refractory chronic immune thrombocytopenic purpura","volume":"77","author":"Mazzucconi","year":"1987","journal-title":"Acta Haematol"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB12","first-page":"275","article-title":"Therapeutic effect of danazol on metrorrhagia in patients with idiopathic thrombocytopenic purpura","volume":"28","author":"Ambriz","year":"1986","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB13","first-page":"219","article-title":"Traitement du purpura thrombop\u00e9nique autoimmun chronique par danazol","volume":"18","author":"Fermand","year":"1985","journal-title":"Actual Hematol"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000206176","article-title":"Danazol for treatment of idiopathic thrombocytopenic purpura","volume":"74","author":"Buelli","year":"1985","journal-title":"Acta Haematol"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2141.1985.tb04070.x","article-title":"The use of danazol in the management of chronic immune thrombocytopenic purpura","volume":"61","author":"McVerry","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000206184","article-title":"Danazol in idiopathic thrombocytopenic purpura","volume":"74","author":"Almagro","year":"1985","journal-title":"Acta Haematol"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB17","first-page":"143","article-title":"The role of danazol in the treatment of refractory idiopathic thrombocytopenic purpura. A report of 22 cases","volume":"32","author":"Fenaux","year":"1990","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB18","first-page":"307","article-title":"Treatment of idiopathic thrombocytopenic purpura with danazol","volume":"40","author":"Ruberto","year":"1995","journal-title":"Sangre"},{"issue":"suppl 2","key":"10.1016\/j.amjmed.2003.12.024_BIB19","first-page":"29","article-title":"Treatment of idiopathic thrombocytopenic purpura in patients refractoriness to or with contraindication for corticosteroids and\/or splenectomy with immunosuppressive therapy and danazol","volume":"78","author":"Schiavotto","year":"1993","journal-title":"Haematologica"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB20","first-page":"1750","article-title":"Low-dose danazol therapy in idiopathic thrombocytopenic purpura","volume":"31","author":"Nozaki","year":"1990","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB21","first-page":"768","article-title":"Danazol in chronic idiopathic thrombocytopenic purpura resistant to corticosteroids","volume":"114","author":"Kotlarek-Haus","year":"1987","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9343(99)80342-8","article-title":"Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00000441-197811000-00002","article-title":"Idiopathic thrombocytopenic purpura in the elderly","volume":"276","author":"Shashaty","year":"1978","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjmed.2003.12.024_BIB24","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/bmj.294.6583.1323","article-title":"Danazol and benign intracranial hypertension","volume":"294","author":"Shah","year":"1987","journal-title":"BMJ"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934304000592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934304000592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:28:15Z","timestamp":1757579295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934304000592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0002934304000592"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2003.12.024","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2003.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}